Glioblastoma multiforme (GBM) is one of the most aggressive and fatal forms of brain cancer, characterized by rapid growth and resistance to conventional therapies. Despite advancements in glioblastoma treatment, the glioblastoma multiforme survival rate remains low, with a median survival